Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results

Go back to Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results

Eyenovia Inc (EYEN) Tops Q4 EPS by 2c

March 25, 2020 4:13 PM EDT

Eyenovia Inc (NASDAQ: EYEN) reported Q4 EPS of ($0.31), $0.02 better than the analyst estimate of ($0.33).

Fourth Quarter 2019 and Recent Business Highlights

Advanced MicroLine for the improvement in near vision in patients with presbyopia towards Phase III development;Deferred development activities for the MicroProst (glaucoma and ocular hypertension) and MicroTears (red eye and itch relief/lubrication) programs;Expanded Scientific Advisory Board with the addition of Mark... More